Unveiling the molecular mechanisms underpinning biorecognition of early-glycated human serum albumin and receptor for advanced glycation end products.
Serum levels of early-glycated albumin are significantly increased in patients with diabetes mellitus and may play a role in worsening inflammatory status and sustaining diabetes-related complications. To investigate possible pathological recognition involving early-glycated albumin and the receptor for advanced glycation end products (RAGE), an early-glycated human serum albumin (HSAgly), with a glycation pattern representative of the glycated HSA form abundant in diabetic patients, and the recombinant human RAGE ectodomain (VC1) were used.
- Biorecognition between the two interactants was investigated by combining surface plasmon resonance (SPR) analysis and affinity chromatography coupled with mass spectrometry (affinity-MS) for peptide extraction and identification.
- SPR analysis proved early-glycated albumin could interact with the RAGE ectodomain with a steady-state affinity constant of 6.05 ± 0.96 × 10-7 M. Such interaction was shown to be specific, as confirmed by a displacement assay with chondroitin sulfate, a known RAGE binder. Affinity-MS studies were performed to map the surface area involved in the recognition. These studies highlighted that a region surrounding Lys525 and part of subdomain IA were involved in VC1 recognition.
- Finally, an in silico analysis highlighted (i) a key role for glycation at Lys525 (the most commonly glycated residue in HSA in diabetic patients) through a triggering mechanism similar to that previously observed for AGEs or advanced lipoxidation end products and (ii) a stabilizing role for subdomain IA.
- Albeit a moderate affinity for complex formation, the high plasma levels of early-glycated albumin and high percentage of glycation at Lys525 in diabetic patients make this interaction of possible pathological relevance.
gentaur.com
Protein Kinase C, Panel, Western Blot Control (PKC) |
|||
| MBS652621-5x1Panel | MyBiosource | 5x1Panel | EUR 3600 |
Control for GCDFP-15, 4 cases (1.5mm)HumanBreastBreastIHC control |
|||
| GCDFP081 | Pantomics | 1.5mm | EUR 50 |
Control for MSH2, 4 cases (1.5mm)HumanDigestive systemColonIHC control |
|||
| MSH2081 | Pantomics | 1.5mm | EUR 50 |
Control for Olig2, 4 cases (1.5mm)HumanNervous systemBrainIHC control |
|||
| OLIG2081 | Pantomics | 1.5mm | EUR 50 |
Core Panel Multi-Tumor control slides, set of 5 |
|||
| TS900 | Innovex | Set of 5 | EUR 145 |
|
Description: Core Panel Multi-Tumor control slides, set of 5 |
|||
Core Panel Multi-Tumor control slides, set of 25 |
|||
| TS900-25 | Innovex | Set of 25 | EUR 425 |
|
Description: Core Panel Multi-Tumor control slides, set of 25 |
|||
Breast Panel Multi-Tumor control slides, set of 5 |
|||
| TS901 | Innovex | Set of 5 | EUR 145 |
|
Description: Breast Panel Multi-Tumor control slides, set of 5 |
|||
Breast Panel Multi-Tumor control slides, set of 25 |
|||
| TS901-25 | Innovex | Set of 25 | EUR 395 |
|
Description: Breast Panel Multi-Tumor control slides, set of 25 |
|||
Rec. Human CD21 protein control for WB |
|||
| CD21-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Control for MSMB, 4 cases (1.5mm)HumanReproductive systemProstateIHC control |
|||
| MSMB081 | Pantomics | 1.5mm | EUR 50 |
Control for PSA, 4 cases (1.5mm)HumanReproductive systemProstateIHC control |
|||
| PSA081 | Pantomics | 1.5mm | EUR 50 |
Control/Blocking peptide for Human WNT-1 |
|||
| WNT111-P | Alpha Diagnostics | 100 ug | EUR 548.4 |
Control for ARG-1, 4 cases (1.5mm)HumanDigestive systemLiverIHC control |
|||
| ARG1081 | Pantomics | 1.5mm | EUR 50 |
Control for BMI-1, 4 cases (1.5mm)HumanRespiratory systemLungIHC control |
|||
| BMI1081 | Pantomics | 1.5mm | EUR 50 |
Control for Thyroglobulin, 4 cases (1.5mm)HumanEndocrine systemThyroidIHC control |
|||
| THYRGB081 | Pantomics | 1.5mm | EUR 50 |
Purified, Human S100 protein control for WB |
|||
| S1002-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Control Animal Genomic DNA Panel, Set of any 5 species |
|||
| G-005 | Zyagen | 5X0.025mg | EUR 720 |
Control Animal Genomic DNA Panel, Set of any 10 species |
|||
| G-010 | Zyagen | 10x0.025mg | EUR 1193 |
Control for CK13, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| CK13081 | Pantomics | 1.5mm | EUR 50 |
Control for CK14, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| CK14081 | Pantomics | 1.5mm | EUR 50 |
Control for CK15, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| CK15081 | Pantomics | 1.5mm | EUR 50 |
Control for CK18, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| CK18081 | Pantomics | 1.5mm | EUR 50 |
Control for CK19, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| CK19081 | Pantomics | 1.5mm | EUR 50 |
Control for CK20, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| CK20081 | Pantomics | 1.5mm | EUR 50 |
Control for CK6, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| CK6081 | Pantomics | 1.5mm | EUR 50 |
Control for CK8, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| CK8081 | Pantomics | 1.5mm | EUR 50 |
Control for EGFR, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| EGFR081 | Pantomics | 1.5mm | EUR 50 |
Control for CEA, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| CEA081 | Pantomics | 1.5mm | EUR 50 |
Control for Desmin, 4 cases (1.5mm)HumanSoft tissuesMulti-organsIHC control |
|||
| DESMIN081 | Pantomics | 1.5mm | EUR 50 |
Control for MUC1, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| MUC1081 | Pantomics | 1.5mm | EUR 50 |
Control for p53, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| P53081 | Pantomics | 1.5mm | EUR 50 |
Control for p57, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| P57081 | Pantomics | 1.5mm | EUR 50 |
Control for p63, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| P63081 | Pantomics | 1.5mm | EUR 50 |
Control for PDX1, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| PDX1081 | Pantomics | 1.5mm | EUR 50 |
Control for SOX2, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| SOX2081 | Pantomics | 1.5mm | EUR 50 |
Control for NDRG1, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| NDRG1081 | Pantomics | 1.5mm | EUR 50 |
Control for S100A9, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| S100A9081 | Pantomics | 1.5mm | EUR 50 |
Human Pancreatic Amylase protein control for Western blot |
|||
| PAMY13-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Control for ALDH1A1, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| ALDH1081 | Pantomics | 1.5mm | EUR 50 |
Control for Stathmin, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| STATHMIN081 | Pantomics | 1.5mm | EUR 50 |
Human Apolipoprotein B protein control for WB |
|||
| APOB21-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Adipsin, Human (Control Protein for Western Blot) |
|||
| MBS653899-01mL | MyBiosource | 0.1mL | EUR 575 |
Adipsin, Human (Control Protein for Western Blot) |
|||
| MBS653899-5x01mL | MyBiosource | 5x0.1mL | EUR 2440 |
Goat IgG (-ve control for flow cytometry) (isotype control) |
|||
| 20011-100 | Alpha Diagnostics | 100 test | EUR 123.6 |
Control for PLAP, 4 cases (1.5mm)HumanReproductive systemMulti-organsIHC control |
|||
| PLAP081 | Pantomics | 1.5mm | EUR 50 |
BSA Control for Age-BSA |
|||
| 2221-BSA | Biovision | each | EUR 210 |
BSA Control for AGE-BSA |
|||
| 35R-AA007 | Fitzgerald | 10 mg | Ask for price |
|
Description: BSA Control for AGE protein (BSA modified), Cat No. 30R-AA007 |
|||
Haptoglobin Human Plasma protein control for WB |
|||
| HGLB18-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Control for COX-2, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| COX2081 | Pantomics | 1.5mm | EUR 50 |
Control for Synaptophysin, 4 cases (1.5mm)HumanNervous systemMulti-organsIHC control |
|||
| SYNAP081 | Pantomics | 1.5mm | EUR 50 |
Control for Thrombomodulin, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| THROMB081 | Pantomics | 1.5mm | EUR 50 |
Control for Cyclin E1, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| CYCLINE1081 | Pantomics | 1.5mm | EUR 50 |
Control for Napsin A, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| NAPSINA081 | Pantomics | 1.5mm | EUR 50 |
Human Native Retinol binding protein (RBP) control for Western |
|||
| RBP41-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Control for Alpha-Actin, 4 cases (1.5mm)HumanSoft tissuesMulti-organsIHC control |
|||
| A-ACTIN081 | Pantomics | 1.5mm | EUR 50 |
Human Hemopexin purified protein control for Western |
|||
| HPEX11-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Control for Cadherin-6, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| CADN6081 | Pantomics | 1.5mm | EUR 50 |
Control for OCT-4, 4 cases (1.5mm)HumanReproductive systemMulti-organsIHC control |
|||
| OCT4081 | Pantomics | 1.5mm | EUR 50 |
Negative Control for Rabbit IgG |
|||
| TA353974 | Origene Technologies GmbH | 100 µl | Ask for price |
Negative Control for Rabbit IgG |
|||
| PC-124 | Kamiya Biomedical Company | Polyclonal | Ask for price |
Negative Control for Mouse IgG1 |
|||
| MC-950 | Kamiya Biomedical Company | NCG01 | Ask for price |
Control for Chromogranin A, 4 cases (1.5mm)HumanNervous systemMulti-organsIHC control |
|||
| CHRA081 | Pantomics | 1.5mm | EUR 50 |
Control Peptide for SNAPtideÒ #520 |
|||
| 525 | List Biological Laboratories | 200nmoles | EUR 600 |
Precision qPCR endogenous control for Human, 150 reactions |
|||
| Z-EC-Human | Novacyt Group | 150 rxns | EUR 217 |
|
Description: Human |
|||
Human Apolipoprotein C-I protein control for WB |
|||
| APOC11-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Purified Human Survivin protein for WB +ve control |
|||
| SURV11-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Scrambled Control for Pri Peptide |
|||
| 069-78 | PHOENIX PEPTIDE | 200 μg | EUR 160.92 |
Human Apolipoprotein C-II protein control for WB |
|||
| APOC22-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Control for ER, 4 cases (1.5mm) |
|||
| ERC081 | Pantomics | 1 | EUR 102 |
|
Description: IHC control array containing 4 breast cancer cases of strong, moderate, weak/nil estrogen receptor (ER) expressers in duplicates |
|||
Control for PR, 3 cases (1.5mm) |
|||
| PRC061 | Pantomics | 1 | EUR 102 |
|
Description: IHC control array containing 3 breast cancer cases of strong, moderate, low/negative progesterone receptor (PR) expressers in duplicates |
|||
Customized Organic Acids Panel-2 in Urine Lyophilized Control Level 1 |
|||
| ZV-3066-02K1-20 | Zivak Technologies | 1 x 3mL | Ask for price |
Human Apolipoprotein C-III protein control for WB |
|||
| APOC32-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Purified human Catalase (CATL) protein control for WB |
|||
| CATL11-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
copy number positive control for custom human assay |
|||
| Z-hu-std | Novacyt Group | each | EUR 217 |
|
Description: Control |
|||
Positive Control Set For Autoimmune |
|||
| MBS315464-1Set | MyBiosource | 1Set | EUR 1625 |
Positive Control Set For Autoimmune |
|||
| MBS315464-5x1Set | MyBiosource | 5x1Set | EUR 7150 |
STT Negative Control for Gelatinase |
|||
| MBS566511-5mg | MyBiosource | 5mg | EUR 485 |
STT Negative Control for Gelatinase |
|||
| MBS566511-5x5mg | MyBiosource | 5x5mg | EUR 2145 |
Control for DOG1, 3 cases (1.5mm) |
|||
| DOG1061 | Pantomics | 1 | EUR 102 |
|
Description: IHC control array containing 3 GIST cases of strong, moderate, weak/nil DOG1 expressers in duplicates |
|||
Control for HER2, 4 cases (1.5mm) |
|||
| HRC081 | Pantomics | 1 | EUR 102 |
|
Description: IHC control array containing 4 breast cancer cases of strong, moderate, low and negative HER2 breast cancer expressers in duplicates |
|||
Control for Ubiquitin Affinity Beads |
|||
| CUB02B-beads | Cytoskeleton | 10 assays | EUR 112.32 |
Human plasma Apolipoprotein E protein control for WB |
|||
| APOE13-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Human Plasma Apolipoprotein J protein control for WB |
|||
| APOJ13-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Human Salivary Amylase protein positive control for WB |
|||
| SAMY16-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Purified, recombinant Human TACE control protein for WB |
|||
| TACE11-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Molecular Dynamics Simulations and Product Vibrational Spectral Analysis for the Reactions of NO2 with 1-Ethyl-3-methylimidazolium Dicyanamide (EMIM+DCA-), 1-Butyl-3-Methylimidazolium Dicyanamide (BMIM+DCA-) and 1-Allyl-3-Methylimidazolium Dicyanamide (AMIM+DCA-).
Direct dynamics trajectory simulations were carried out for the NO2 oxidation of EMIM+DCA–, which were aimed at probing the nature of the primary and secondary reactions in the system.
Guided by trajectory results, reaction coordinates and potential energy diagrams were mapped out for NO2 with EMIM+DCA– as well as with its analogues BMIM+DCA– and AMIM+DCA–. Reactions of the dialkylimidazolium-DCA ILs are all initiated by proton transfer and/or alkyl abstraction between 1,3-dialkylimidazolium cations and DCA– anion, of which two exoergic pathways are particularly relevant to their oxidation activities.
One pathway is the transfer of a Hβ-proton from the ethyl, butyl or allyl group of the dialkylimidazolium cation to DCA– that results in concomitant elimination of the corresponding alkyl as a neutral alkene, and the other pathway is SN2-alkyl abstraction by DCA–. The intra-ion-pair reaction products, including [dialkylimidazolium – HC2+], alkylimidazole, alkene, alkyl-DCA, HDCA and DCA–, react with NO2 and favor formation of nitrite (-ONO) complexes over nitro (-NO2) complexes, albeit the two complex structures have similar formation energies.
- The exoergic intra-ion-pair reactions in the dialkylimidazolium-DCA ILs account for their significantly higher oxidation activities over the previously reported 1-methyl-4-amino-1,2,4-triazolium dicyanamide [Liu, J.; et al. J. Phys. Chem. B, 2019, 123, 2956], and for the relatively higher reactivity of BMIM+DCA– versus AMIM+DCA– as BMIM+ has a higher reaction path degeneracy for intra-ion-pair Hβ-proton transfer and its Hβ-transfer is more energetically favorable.
- To validate and directly compare our computational results with spectral measurements in the ILs, infrared and Raman spectra of BMIM+DCA– and AMIM+DCA– and their products with NO2 were calculated using an ionic liquid solvation model. The simulated spectra reproduced all of the vibrational frequencies detected in the reactions of BMIM+DCA– and AMIM+DCA– IL droplets with NO2 [as reported by Brotton, S. J.; et al. J Phys. Chem. A, 2018, 122, 7351; and Lucas, M.; et al. J. Phys. Chem. A, 2019, 123, 400].
25 mm Diameter Solid Titanium Tip |
|||
| 0-120-0015 | Biologics | 25 mm | EUR 614 |
Flat Replaceable Tips 13 mm Diameter Flat Titanium Tip |
|||
| 0-120-0016 | Biologics | 13 mm | EUR 86 |
|
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
|||
Flat Replaceable Tips 19 mm Diameter Flat Titanium Tip |
|||
| 0-120-0017 | Biologics | 19 mm | EUR 92 |
|
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
|||
Flat Replaceable Tips 25 mm Diameter Flat Titanium Tip |
|||
| 0-120-0018 | Biologics | 25 mm | EUR 100 |
|
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
|||
Titanium Cup Tip, 250 ml |
|||
| 0-120-0019 | Biologics | 250 ml | EUR 1377 |
|
Description: includes Interface Washers |
|||
Microtube Tray, 8 Position (for 250 ml Cup Tip) |
|||
| 0-120-0021 | Biologics | each | EUR 113 |
|
Description: includes Interface Washers |
|||
Continuous Flow Chamber |
|||
| 0-120-0026 | Biologics | each | EUR 774 |
|
Description: includes Interface Washers |
|||
Interface Washers 1.5” Diameter, 5/Pkg |
|||
| 0-120-003 | Biologics | 1.5'' Diameter | EUR 31 |
13 mm Diameter Solid Titanium Extender Tip |
|||
| 0-120-0032 | Biologics | 13 mm | EUR 301 |
13 mm Diameter Tapped Titanium Extender Tip |
|||
| 0-120-0033 | Biologics | 13 mm | EUR 362 |
19 mm Diameter Solid Titanium Extender Tip |
|||
| 0-120-0034 | Biologics | 19 mm | EUR 315 |
19 mm Diameter Tapped Titanium Extender Tip |
|||
| 0-120-0035 | Biologics | 19 mm | EUR 375 |
25 mm Diameter Solid Titanium Extender Tip |
|||
| 0-120-0036 | Biologics | 25 mm | EUR 328 |
25 mm Diameter Tapped Titanium Extender Tip |
|||
| 0-120-0037 | Biologics | 25 mm | EUR 389 |
KoldPod, 1.5ml Micro Tube |
|||
| 0-120-0038 | Biologics | 1.5 ml | EUR 152 |
|
Description: Thermo conductive tube pods |
|||
KoldPod, 15ml Conical Tube |
|||
| 0-120-0039 | Biologics | 15 ml | EUR 275 |
|
Description: Thermo conductive tube pods |
|||
KoldPod, 50ml Conical Tube |
|||
| 0-120-0040 | Biologics | 50 ml | EUR 290 |
|
Description: Thermo conductive tube pods |
|||
Model 150 V/T Ultrasonic Homogenizer |
|||
| 0-121-0002 | Biologics | 210-240V/50-60Hz | EUR 2920 |
|
Description: Delivers up to 150 Watts of ultrasonic power to the Titanium Tip. The Timer and Duty Cycle function increase preciosion in sample processing processing. |
|||
Model 300 V/T Ultrasonic Homogenizer |
|||
| 0-122-0002 | Biologics | 210-240V/50-60Hz | EUR 3520 |
|
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip. The Timer and Duty Cycle function increase preciosion in sample. |
|||
SONABOZ Sound Abating Chamber |
|||
| 0-125-0001 | Biologics | each | EUR 1020 |
|
Description: Reduces cavitational sound emitted during processing. |
|||
Model 3000 Ultrasonic Homogenizer |
|||
| 0-127-0002 | Biologics | 210-240V/50-60Hz | EUR 4120 |
|
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip and includes an intergrated Sound Abating Chmaber to reduce cavitational sound emitted during processing. The Timer and Duty Cycle function increase preciosion in sample. |
|||
Model 3000MP Ultrasonic Homogenizer |
|||
| 0-128-0002 | Biologics | 210-240V/50-60Hz | EUR 4720 |
|
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip with preciosion control from a microprocessor and a graphical user interface displayed on a large (145 mm) LCD display. The integrated Sound Abating Chamber reduces cavitational sound emitted during processing. |
|||
OMNICON® Zone Reader, 210-240V/50-60Hz |
|||
| 0-131-0002 | Biologics | 210-240V/50-60Hz | EUR 35200 |
|
Description: Designed to Perform multi-plate Assays on round 90/100mm Petri Dishes. The integrated LED illumination system provides transmitted light for brightfield and darkfield illumination of transparent media. |
|||
OMNI-Noculator Peni Cylinder Filler, 210-240V/50-60Hz |
|||
| 0-134-0002 | Biologics | 210-240V/50-60Hz | EUR 32200 |
|
Description: A robotic liquid handling system designed to dispense Peni Cylinders and fill Peni Cylinders with the corresponding antibiotic liquid sample. |
|||
Peni Cylinder Dispenser with Manual Hopper |
|||
| 0-144-0002 | Biologics | each | EUR 5406 |
|
Description: Dispenser can be configured to dispense 4 or 6 Peni Cylinders onto a petri dish. |
|||
Peni Cylinder Dispenser with Motorized Hopper, 100-240V/50-60Hz |
|||
| 0-144-0003 | Biologics | 100-240V/50-60Hz | EUR 6254 |
|
Description: The motorized hopper can be configured to dispense 4 or 6 Peni Cylinders onto a petri Dispenser can be disassembled for disinfection. |
|||
Stainless Steel Peni Cylinder with Flat Face |
|||
| 0-144-0005 | Biologics | 6mm I.D. x 8mm O.D. x 10mm Long | EUR 399 |
|
Description: sold in packages of 100 pieces |
|||
Stainless Steel Peni Cylinder with Chamfered Face |
|||
| 0-144-0006 | Biologics | 6mm I.D. x 8mm O.D. x 10mm Long | EUR 412 |
|
Description: sold in packages of 100 pieces |
|||
Custom development of ELISAs for other species or antibody isotypes not listed in the catalog. Custom testing of samples for IgG/IgM/IgA or total (IgG+IgM+IgA) |
|||
| 000-CUS | Alpha Diagnostics | Custom | EUR 602 |
Alpha-Bungarotoxin, CF®405S, 500 ug |
|||
| 00002 | Biotium | 1UG | EUR 527 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-bungarotoxin, CF405s |
|||
| 00002 | Cusabio | 500uG | EUR 594 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-Bungarotoxin, CF®405S, 500 ug |
|||
| 00002-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®405S 100ug |
|||
| 00002-100ug | Biotium | 100uG | EUR 132 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®680R, 500 ug |
|||
| 9-00003 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®680R, 500 ug |
|||
| 00003-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®680R 100ug |
|||
| 9-00003 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®640R, 500 ug |
|||
| 9-00004 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®640R, 500 ug |
|||
| 00004-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®640R 100ug |
|||
| 9-00004 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®488A, 500 ug |
|||
| 9-00005 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®488A, 500 ug |
|||
| 00005-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin CF®488A 100ug |
|||
| 9-00005 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®568, 500 ug |
|||
| 9-00006 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®568, 500 ug |
|||
| 00006-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®568 100ug |
|||
| 9-00006 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®594, 500 ug |
|||
| 9-00007 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®594, 500 ug |
|||
| 00007-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin CF®594 100ug |
|||
| 9-00007 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®633, 500 ug |
|||
| 9-00009 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®633, 500 ug |
|||
| 00009-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®633 100ug |
|||
| 9-00009 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
SARS-CoV-2 Indicator Cell Line for RNA Replication - GFP Reporter only |
|||
| 0001-PP-001 | IBT Bioservices | 1 cell line (can order x amount) | EUR 12000 |
|
Description: SARS-CoV-2 GFP reporter cell line using HEK293T (ACE2/TMPRSS2) cells |
|||
Alpha-Bungarotoxin, 1 mg |
|||
| 00010-1 | Biotium | 1MG | EUR 193 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, 1 mg |
|||
| 00010-1-1 | Biotium | EA | EUR 193 |
Fluorescein-Alpha-Bungarotoxin, 500 ug |
|||
| 00011 | Biotium | 500uG | EUR 376 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Fluorescein-Alpha-Bungarotoxin, 500 ug |
|||
| 00011-1 | Biotium | EA | EUR 376 |
Tetramethylrhodamine-Alpha-Bungarotoxin, 500 ug |
|||
| 00012 | Biotium | 500uG | EUR 394 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Tetramethylrhodamine-Alpha-Bungarotoxin, 500 ug |
|||
| 00012-1 | Biotium | EA | EUR 394 |
Fluorescein-alpha-bungarotoxin, 10x50ug |
|||
| 00013 | Biotium | 10ST | EUR 436 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Fluorescein-alpha-bungarotoxin, 10x50ug |
|||
| 00013-1 | Biotium | EA | EUR 436 |
Tetramethylrhodamine-A-Bungarotoxin, 10x50 ug |
|||
| 00014 | Biotium | 10ST | EUR 494 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Tetramethylrhodamine-A-Bungarotoxin, 10x50 ug |
|||
| 00014-1 | Biotium | EA | EUR 494 |
Sulforhodamine 101-Alpha-Bungarotoxin, 500 ug |
|||
| 00015 | Biotium | 500uG | EUR 494 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Sulforhodamine 101-Alpha-Bungarotoxin, 500 ug |
|||
| 00015-1 | Biotium | EA | EUR 494 |
Sulforhodamine 101-Alpha-Bungarotoxin, 50 ug |
|||
| 00016 | Biotium | 10ST | EUR 560 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Sulforhodamine 101-Alpha-Bungarotoxin, 50 ug |
|||
| 00016-1 | Biotium | EA | EUR 560 |
Biotin-XX-A-Bungarotoxin, 500 ug |
|||
| 00017 | Biotium | 500uG | EUR 455 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Biotin-XX-A-Bungarotoxin, 500 ug |
|||
| 00017-1 | Biotium | EA | EUR 455 |
Alpha-Bungarotoxin, CF®555, 500 ug |
|||
| 9-00018 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®555, 500 ug |
|||
| 00018-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®555 100ug |
|||
| 9-00018 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Acrylamide, Chemzymes Ultra Pure® |
|||
| 00019-100 | Polysciences Europe GmbH | 100g | EUR 101.52 |
|
Description: 79-06-1 |
|||
Acrylamide, Chemzymes Ultra Pure® |
|||
| 00019-500 | Polysciences Europe GmbH | 500g | EUR 270 |
|
Description: 79-06-1 |
|||
Biotin-cAMP, 1 mg |
|||
| 00020 | Biotium | 1MG | EUR 298 |
|
Description: N/A |
|||
Biotin-cAMP, 1 mg |
|||
| 00020-1 | Biotium | 20ST | EUR 298 |
|
Description: N/A |
|||
Biotin-cAMP, 50 ug |
|||
| 00020-1-1 | Biotium | EA | EUR 414 |
Biotin-cGMP, 1 mg |
|||
| 00021 | Biotium | 1MG | EUR 331 |
|
Description: N/A |
|||
Biotin-cGMP, 1 mg |
|||
| 00021-1 | Biotium | 20ST | EUR 331 |
|
Description: N/A |
|||
Biotin-cGMP, 20x50 ug |
|||
| 00021-1-1 | Biotium | EA | EUR 447 |
Cyanine 644-cAMP, 1 mg |
|||
| 00022 | Biotium | 1MG | EUR 496 |
|
Description: N/A |
|||
Cyanine 644-cAMP, 1 mg |
|||
| 00022-1 | Biotium | 20ST | EUR 496 |
|
Description: N/A |
|||
Cyanine 644-cAMP, 20x50 ug |
|||
| 00022-1-1 | Biotium | EA | EUR 647 |
Fluorescein Methotrexate, Triammonium Salt, 1 mg |
|||
| 00023 | Biotium | 1MG | EUR 285 |
|
Description: N/A |
|||
Fluorescein Methotrexate, Triammonium Salt, 1 mg |
|||
| 00023-1 | Biotium | EA | EUR 285 |
Staurosporine |
|||
| 00025 | Biotium | 100uG | EUR 100 |
|
Description: N/A |
|||
Staurosporine |
|||
| 00025-1 | Biotium | EA | EUR 100 |
Alpha-Bungarotoxin, CF®543, 500 ug |
|||
| 00026 | Biotium | 500uG | EUR 527 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®543, 500 ug |
|||
| 00026-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®543, 100 ug |
|||
| 00026-100ug | Biotium | 1UG | EUR 132 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Rhodamine Phalloidin 300U |
|||
| 00027 | Biotium | 300 | EUR 364 |
|
Description: N/A |
|||
Rhodamine Phalloidin 300U |
|||
| 00027-1 | Biotium | EA | EUR 364 |